Guest mode: your portfolio is kept in this browser until you connect.

Sys onlineGuest--:-- local
ALGNhealthcarenasdaqgs

Align Technology logoAlign Technology

Align Technology (ALGN) is a healthcare company; Yahoo Finance files it under medical devices.

Price

$174.26

+4.98% on Nov 9

Risk

High

44.1% vol · 30d

share this asset

Key facts, as of

As of November 9, 2026, Align Technology (ALGN) trades at $174.26, up 29.2% over the past year. Its 52-week range runs from $130.23 to $200.44; the price is 13.1% below that high. It is 76.4% below its all-time high of $737.45, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +74.5%, against +316.3% for the S&P 500 (SPY). It sits 3.4% above its 200-day average of $168.59. Its 30-day volatility is 44.1% annualized, which we rate high risk. It has a trailing P/E of 25.4.

Cite: Portfolio Terminal, "Align Technology (ALGN) stock analysis", 2026-11-09. https://portfolio-terminal.com/analyse/algn

01Market

Where it trades today

Market cap

$12.28B

Price / earnings

25.4x

Beta

1.74

swings more than the market

Dividend yield

none

Volume

2.39M

avg 949.2K

50-day average

$150.71

200-day average

$168.59

30-day move

+22.1%

52-week range13.1% below the high
low $130.23$174.26high $200.44

trading 63% of the way up its 52-week range

02Price

How the price has moved

30-day price+22.11%
30 days ago$142.71 → $174.26today
1-year performance+27.1%
$148$165$182NovDecJanFebMarAprMayJunJulAugSepOct
ALGN · 52 weeks$137.13 → $174.26
03History

How far it is from its record

All-time high

$737.45

Sep 2021, intraday

From the high

−76.4%

+323.2% to regain it

History from

Jan 2001

monthly, Yahoo Finance

10 years

+74.5%

SPY +316.3%

Align Technology (ALGN) is 76.4% below its all-time high of $737.45, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +74.5%, against +316.3% for the S&P 500 (SPY).

ALGN since Jan 2001−76.4% from the high
$383$575$174.26$737.45 · Sep 202120102020
Month-end closes, split-adjusted · dashed: today
04Read

The read, from its own figures

the read3 sources

What its numbers say

  • ALGN closes above its 50-day average ($150.71) while the 50-day is still under the 200-day ($168.59): a rebound inside a longer decline, not yet an uptrend.
  • At $174.26, ALGN is 13.1% below its 1-year high of $200.44, set on April 21, 2026, and 33.8% above its 1-year low of $130.23 (November 18, 2025).
  • Over the past month ALGN rose 22.1%, from $142.71 to $174.26.
  • ALGN trades at 25.4x its last twelve months of earnings and 14.2x the next twelve months' estimate, so analysts expect earnings 79.3% higher.
  • Its P/E is 26.8% below the 34.7x median of the 3 other medical devices companies we track (ABT, SYK, BSX).
  • ALGN's 30-day volatility, 44.1% a year, works out to a typical daily move of about 2.8%.
  • Yahoo Finance puts its beta at 1.74: over five years of monthly returns, ALGN moved about 1.74% for each 1% move of the S&P 500.
  • The last session traded 2.3x ALGN's average daily volume of the 30 sessions before it.

What would change the read

  • The rebound holds while it closes above the 50-day average, $150.71 (−13.5%); it becomes an uptrend when the 50-day climbs 11.9% to cross the 200-day at $168.59.
  • A close above $200.44 (+15.0%) would be a new 1-year high; below $130.23 (−25.3%), a new 1-year low.

How it is computed

  • Prices are Yahoo Finance's daily candles for ALGN, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
  • The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
  • Peers are the other companies Yahoo Finance files under medical devices among the assets we track, not a full industry screen; the median counts those with a positive P/E.
  • Every sentence here is written by code from those figures, refreshed daily; nobody edits it for ALGN by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.

Sources

  • Yahoo Finance quote and daily historyopen →

    The candles, the averages' inputs and the quote fields used for ALGN. Last refresh: Nov 9, 2026, 9:37 PM UTC.

  • How Portfolio Terminal computes its figuresopen →

    The methodology page behind the analytics and their refresh cadence.

  • Industry classification

    Yahoo Finance's industry, as stored in our list of tracked assets: Medical Devices.

Computed, not written · Code turns the figures above into these sentences; market data refreshed 11/9/2026, 9:37:29 PM. Page built by Julien Esnault. A description of the data, not advice.
05About

What Align Technology does

profile

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus;…

Employees

20,180

Industry

Medical Instruments & Supplies

Headquarters

Tempe, United States

06Analyst Consensus

What analysts expect

ALGN carries a buy consensus from 14 analysts, with an average price target of $185.79 versus $174.26 today (+6.6%). Targets are estimates and can move quickly after earnings.

Consensus

Buy

Average target

$185.79

$160.00 to $210.00

Upside to target

+6.6%

Analysts covering

14

Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.

07Financial Strength

How the business is doing

ALGN generated $4.16B in trailing revenue (1.9% year over year), with a 11.8% net margin, and $573.70M of free cash flow, supported by $998.47M of net cash.

Revenue (TTM)

$4.16B

Net margin

11.8%

Revenue growth

1.9%

Free cash flow

$573.70M

Gross margin

71.5%

Operating margin

20.1%

Return on equity

11.9%

Total cash

$1.14B

Total debt

$146.46M

Earnings growth

143.6%

08Annual Financials

The numbers, year by year

annual financials4 years
Fiscal yearRevenueGross profitOperating incomeNet incomeEPSFree cash flow
2025$4.03B$2.71B$585.31M$410.35M$5.66$490.78M
2024$4.00B$2.80B$671.76M$421.36M$5.63$622.65M
2023$3.86B$2.71B$656.65M$445.05M$5.82$608.06M
2022$3.73B$2.63B$654.05M$361.57M$4.62$276.83M
Company filings via Yahoo Finance. Refreshed 11/9/2026.
09Next Earnings

When it reports next

Next report

Oct 28, 2026

EPS estimate

$3.05

Revenue estimate

$1.02B

Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.

10ETFs

Which ETFs hold it

ALGN is in 11 of the 54 ETFs we track. It weighs most in RSP: 0.19% of the fund, holding #340 of 504.

etfs holding it11 of 54 funds
RSP0.19%#340 of 504XLV0.15%#57 of 62VB0.12%#250 of 1,301CSPX0.01%#482 of 503SPY0.01%#483 of 504IVV0.01%#483 of 503VUAA0.01%#481 of 503VOO0.01%#482 of 505ITOT0.01%#653 of 2,423VTI0.01%#653 of 3,516VT<0.01%#1409 of 10,155
11Industry

How its figures compare with those peers

versus its peersALGN vs the median of ABT, SYK, BSX
metricALGNmedian · ngap
price / earnings25.4x34.7x · 3−27%
beta1.740.58 · 3+197%
dividend yield0.00%1.08% · 3−100%
30-day volatility44.1%45.3% · 3−3%
Live Yahoo Finance figures for each name; n counts the peers that have the figure.
12Peers

Companies in the same industry

ALGN beside the other companies Yahoo Finance files under medical devices among the assets we track (ABT, SYK, BSX, largest first).

peers4 companies
companypricemarket cap
Align Technology logoALGN$174.26$12.28B
Abbott Laboratories logoABT$110.51$191.40BStryker Corporation logoSYK$325.73$124.00BBoston Scientific logoBSX$44.02$63.81B
Any row opens that company's own analysis.
13Technicals

What the chart is saying

Back above its 50-day average, still under the long-term trend.

recovering
algn · daily
50-day 151200-day 169resistancesupport
1401501601701907030RSI 14 · 70volR 184R 176S 165S 154174JunJulAugSepOctNov
Daily candles · ALGNLevels are zones where the price turned at least twice in the last year. Last close $174.26 on 2026-11-09.

RSI (14)

70

overbought

vs 50-day

+15.6%

avg $150.71

vs 200-day

+3.4%

avg $168.59

From 1-year high

−13.1%

high $200.44 · 2026-04-21

levels and the read44% annualized vol · 30d
resistance$183.51turned here 3×+5.3%
resistance$175.89turned here 3×+0.9%
support$164.77turned here 8×−5.4%
support$153.78turned here 4×−11.8%
  • Price is 15.6% above its 50-day average and 3.4% above its 200-day.
  • The 50-day crossed below the 200-day on 2026-09-09 (a “death cross”).
  • RSI at 70 is overbought: strong momentum, and stretched.
  • The nearest ceiling is $175.89 (+0.9%), the nearest floor $164.77 (-5.4%).

A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.

14Questions

Questions people ask about it

questions8 answered

How is ALGN valued right now?

Align Technology trades at 25.4 times its last twelve months of earnings and 14.2 times the next twelve months' estimate (Yahoo Finance, November 9, 2026). On the chart: back above its 50-day average, still under the long-term trend. Price is 15.6% above its 50-day average and 3.4% above its 200-day.

What is the risk level of ALGN?

Based on 30-day volatility of 44.1%, ALGN has HIGH risk. Its beta of 1.74 means it has swung more than the S&P 500 over the last five years.

Does ALGN pay dividends?

Yahoo Finance shows no dividend yield for Align Technology (November 9, 2026).

How far is ALGN from its all-time high?

Align Technology is 76.4% below its all-time high of $737.45, reached in September 2021. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +74.5%, against +316.3% for the S&P 500 (SPY).

Which ETFs hold ALGN?

11 of the 54 popular ETFs we track hold Align Technology. The largest weights: RSP (0.19%), XLV (0.15%), VB (0.12%), CSPX (0.01%) and SPY (0.01%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.

How much of VOO is ALGN?

0.01%, as of September 30, 2026: ALGN is holding #482 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.15 in Align Technology.

What is the analyst price target for ALGN?

The average analyst price target for Align Technology (ALGN) is $185.79 based on 14 analyst estimates, about 6.6% above the current price of $174.26. The published range runs from $160.00 to $210.00.

How much revenue does ALGN generate?

Align Technology reported $4.16B in trailing twelve-month revenue. Revenue growth is running at 1.9% year over year. Net margin sits at 11.8%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.

Compare ALGN with anything

Five years side by side: what $10,000 became, how far each fell, whether they move together.

Align Technology logo